ResearcherUniversity of CambridgeActive in the last 2 years
Joaquín Araos Henríquez
Matched on ORCID iD 0000-0002-0901-7672; OpenAlex author ID A5103238351. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2022: 1 paper · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 3 papers
Papers 8
- Multi-stromal organoid co-culture modelling reveals epithelial-fibroblast heterogeneity in pancreatic cancer and pancreatitis. Co-author DOI 10.1038/s41556-026-02057-w↗
- Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant cell biology and therapy response Co-author DOI 10.64898/2026.02.02.703350↗
- TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis Co-author DOI 10.64898/2026.09.08.750042↗
- SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-2330↗
- EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. First author DOI 10.1016/j.ccell.2023.12.002↗
- Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. First author DOI 10.1158/0008-5472.can-23-3419↗
- Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back. First author DOI 10.1242/dmm.050624↗
- Tracing back to one of the origins of immune evasion in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.05.002↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giulia Biffi · 8 shared papers, 2022–2026 · strength 1.92
- Paper Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back. DOI 10.1242/dmm.050624↗
- Paper Tracing back to one of the origins of immune evasion in pancreatic cancer. DOI 10.1016/j.ccell.2022.05.002↗
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Eloise G. Lloyd · 6 shared papers, 2024–2026 · strength 1.43
- Paper Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back. DOI 10.1242/dmm.050624↗
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Paper TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis DOI 10.64898/2026.09.08.750042↗
- Priscilla S.W. Cheng · 5 shared papers, 2024–2026 · strength 1.07
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Paper TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis DOI 10.64898/2026.09.08.750042↗
- Paper Multi-stromal organoid co-culture modelling reveals epithelial-fibroblast heterogeneity in pancreatic cancer and pancre… DOI 10.1038/s41556-026-02057-w↗
- Gianluca Mucciolo · 5 shared papers, 2024–2026 · strength 1.07
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Paper TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis DOI 10.64898/2026.09.08.750042↗
- Paper Multi-stromal organoid co-culture modelling reveals epithelial-fibroblast heterogeneity in pancreatic cancer and pancre… DOI 10.1038/s41556-026-02057-w↗
- Wenlong Li · 3 shared papers, 2025–2026 · strength 0.65
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Paper Multi-stromal organoid co-culture modelling reveals epithelial-fibroblast heterogeneity in pancreatic cancer and pancre… DOI 10.1038/s41556-026-02057-w↗
- Paper SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer. DOI 10.1158/0008-5472.can-24-2330↗
- Rebecca J. Brais · 3 shared papers, 2025–2026 · strength 0.65
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Paper Multi-stromal organoid co-culture modelling reveals epithelial-fibroblast heterogeneity in pancreatic cancer and pancre… DOI 10.1038/s41556-026-02057-w↗
- Paper SMAD4 and KRAS Status Shapes Cancer Cell-Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer. DOI 10.1158/0008-5472.can-24-2330↗
- Debasmita Mukherjee · 2 shared papers, 2026 · strength 0.46
- Paper Cross-species graph-embedding unmasks the ageing microenvironment as a key determinant of pancreatic cancer malignant c… DOI 10.64898/2026.02.02.703350↗
- Paper TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis DOI 10.64898/2026.09.08.750042↗
- Bristi Basu · 1 shared paper, 2026 · strength 0.22
- Vincenzo Corbo · 1 shared paper, 2025 · strength 0.20
- Lisa Veghini · 1 shared paper, 2025 · strength 0.20
- Giuseppina Caligiuri · 1 shared paper, 2024 · strength 0.16
- Thomas Knösel · 1 shared paper, 2024 · strength 0.16
- Pedro Antonio Pérez-Mancera · 1 shared paper, 2024 · strength 0.16
- Camino Bermejo‐Rodríguez · 1 shared paper, 2024 · strength 0.16
- Lawrence N. Barrera · 1 shared paper, 2024 · strength 0.16
- Robert Grützmann · 1 shared paper, 2024 · strength 0.16
- Albrecht Neeße · 1 shared paper, 2024 · strength 0.16
- Youngkyu Park · 1 shared paper, 2024 · strength 0.16
- Christian P. Pilarsky · 1 shared paper, 2024 · strength 0.16
- David Arthur Tuveson · 1 shared paper, 2024 · strength 0.16
- Daniel Öhlund · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.